MedPath

Retinal Vascular Network and Obstructive Sleep Apnea

Completed
Conditions
Obstructive Sleep Apnea Syndrome
Interventions
Other: complete ophthalmological examination
Registration Number
NCT03979001
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

Obstructive sleep apnea syndrome (OSA) is thought to lead to systemic vascular lesions that may be preceded by early microvascular lesions in the eyes and in particular in the retina. The improvement of ophthalmological imaging techniques by OCTangiography allows a precise non-invasive study of the retinal microvascular network. This new rapid and non-invasive retinal imaging tool could reveal micro-vascular lesions related to OSA. To the investigator's knowledge, this would be the first OCT-angiography description of a cohort of patients with OSA. If these results are confirmed, it would be interesting to study the correlation between these micro-vascular lesions and the cardiovascular risk of his patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
166
Inclusion Criteria
  • person who has given oral consent
  • person who can be followed throughout the study
  • adult

Patient group:

  • Patient seen in sleep apnea screening consultation by a pulmonologist and referred for polysomnography diagnosis of OSA

Control Group:

  • Person initially without obstructive sleep apnea syndrome
Exclusion Criteria
  • a person who is not affiliated to or not a beneficiary of the national health insurance system
  • person subject to a measure of legal protection (curatorship, guardianship)
  • person subject to a safeguard of justice
  • pregnant, parturient or breastfeeding woman
  • adult incapable or unable to consent
  • person with a contraindication to Tropicamide or Neosynephrine
  • person with a history of eye disease affecting ocular circulation (examples: acute anterior ischemic optic neuropathy, retinal central artery occlusion, retinal central vein occlusion, diabetic retinopathy, glaucoma, uncontrolled hypertonia, AMD, severe myopia...)

Control Group:

  • person with a history of chronic lung problems (e.g. COPD, chronic respiratory failure, etc.)

  • person with at least one of the following risk factors for obstructive sleep apnea syndrome:

    • Obesity with IMC≥30
    • Alcohol consumption > 3 glasses per day

Exclusion criteria: positive result in one of the 3 self-questionnaires

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patientscomplete ophthalmological examinationPatients referred for polysomnography diagnosis of obstructive sleep apnea syndrome
Primary Outcome Measures
NameTimeMethod
Measurement of macular and peri-papillary retinal vascular density of the superficial and deep capillary plexusesChange from baseline at 24 months
Measurement of macular and peri-papillary retinal infusion density of the superficial and deep capillary plexusesChange from baseline at 24 months
Measurement of the surface of the macular avascular zone of the superficial and deep capillary plexusesChange from baseline at 24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Dijon Bourogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath